GP1BA and autoimmune thrombocytopenic purpura: This is the first study in which a difference in therapeutic responsiveness to steroids was revealed between anti-GPIIbIIIa- and anti-GPIbα-mediated ITP, and the mechanisms underlying this difference are currently under investigation.